The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.
Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy
Open accessAbstract
Nanotechnology has been the latest approach for diagnosis and treatment of cancer, which opens up a new alternative therapeutic drug delivery option to treat disease. Nanoparticles (NPs) display a broad role in cancer diagnosis and has various advantages over the other conventional chemotherapeutic drug delivery. NPs possess more specific and efficient drug delivery to the targeted tissue, cell, or organs and minimize the risk of side effects. NPs undergo passive and active mode of drug targets to the tumor area with less elimination of the drug from the system. Size and surface characteristics of nanoparticles play a crucial role in modulating nanocarrier efficiency and the biodistribution of chemo drugs in the body. Several types of nanocarriers, such as polymers, dendrimers, liposome-based, and carbon-based, are studied widely in cancer therapy. Although FDA approved very few nanotechnology drugs for cancer therapy, a large number of studies are undergoing for the development of novel nanocarriers for potent cancer therapy. In this review, we discuss details of the nano-based therapeutics and diagnostics strategies, and the potential use of nanomedicines in cancer drug delivery and cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics
Michalet, X., Pinaud, F. F., Bentolila, L. A., Tsay, J. M., Doose, S., Li, J. J., Sundaresan, G., Wu, A. M., Gambhir, S. S., & Weiss, S. (2005) · Science · doi:10.1126/science.1104274 · Cited by 7,790
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian Cells
Chithrani, B. D., Ghazani, A. A., & Chan, W. C. W. (2006) · Nano Letters · doi:10.1021/nl052396o · Cited by 4,879
In vivo cancer targeting and imaging with semiconductor quantum dots
Gao, X., Cui, Y., Levenson, R. M., Chung, L. W. K., & Nie, S. (2004) · Nature Biotechnology · doi:10.1038/nbt994 · Cited by 4,772
Cancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,920
Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity
Boisselier, E., & Astruc, D. (2009) · Chemical Society Reviews · doi:10.1039/b806051g · Cited by 2,842
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
Tang, F., Li, L., & Chen, D. (2012) · Advanced Materials · doi:10.1002/adma.201104763 · Cited by 2,836
Danhier, F., Feron, O., & Préat, V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,800
The blood-brain barrier: Bottleneck in brain drug development
Pardridge, W. M. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.3 · Cited by 2,798
Shape effects of filaments versus spherical particles in flow and drug delivery
Geng, Y., Dalhaimer, P., Cai, S., Tsai, R., Tewari, M., Minko, T., & Discher, D. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.70 · Cited by 2,565
Xia, T., Kovochich, M., Liong, M., Mädler, L., Gilbert, B., Shi, H., Yeh, J. I., Zink, J. I., & Nel, A. E. (2008) · ACS Nano · doi:10.1021/nn800511k · Cited by 2,469
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
Tacar, O., Sriamornsak, P., & Dass, C. R. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2012.01567.x · Cited by 2,465
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
Cabral, H., Matsumoto, Y., Mizuno, K., Chen, Q., Murakami, M., Kimura, M., Terada, Y., Kano, M. R., Miyazono, K., Uesaka, M., et al. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.166 · Cited by 2,429
A Toxicologic Review of Quantum Dots: Toxicity Depends on Physicochemical and Environmental Factors
Hardman, R. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.8284 · Cited by 2,303
Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
Wicki, A., Witzigmann, D., Balasubramanian, V., & Huwyler, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.030 · Cited by 1,901
Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles
O'Neal, D. P., Hirsch, L. R., Halas, N. J., Payne, J. D., & West, J. L. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.02.004 · Cited by 1,849
Immunotargeted Nanoshells for Integrated Cancer Imaging and Therapy
Loo, C., Lowery, A., Halas, N., West, J., & Drezek, R. (2005) · Nano Letters · doi:10.1021/nl050127s · Cited by 1,792
Toxicity of Gold Nanoparticles Functionalized with Cationic and Anionic Side Chains
Goodman, C. M., McCusker, C. D., Yilmaz, T., & Rotello, V. M. (2004) · Bioconjugate Chemistry · doi:10.1021/bc049951i · Cited by 1,601
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
Din, F. U., Aman, W., Ullah, I., Qureshi, O. S., Mustapha, O., Shafique, S., & Zeb, A. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s146315 · Cited by 1,577
Solid lipid nanoparticles for parenteral drug delivery
Wissing, S. A., Kayser, O., & Müller, R. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.002 · Cited by 1,495
Toxicity of Silver Nanoparticles to Chlamydomonas reinhardtii
Navarro, E., Piccapietra, F., Wagner, B., Marconi, F., Kaegi, R., Odzak, N., Sigg, L., & Behra, R. (2008) · Environmental Science & Technology · doi:10.1021/es801785m · Cited by 1,457
Gabizón, A., Catane, R., Uziely, B., Kaufman, B., Safra, T., Cohen, R., Martin, F., Huang, A., & Barenholz, Y. (1994) · PubMed · Cited by 1,382
Inhaling medicines: delivering drugs to the body through the lungs
Patton, J. S., & Byron, P. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2153 · Cited by 1,331
Particle shape: A new design parameter for micro- and nanoscale drug delivery carriers
Champion, J. A., Katare, Y. K., & Mitragotri, S. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.03.022 · Cited by 1,206
Parodi, A., Quattrocchi, N., van de Ven, A. L., Chiappini, C., Evangelopoulos, M., Martinez, J. O., Brown, B. S., Khaled, S. Z., Yazdi, I. K., Enzo, M. V., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.212 · Cited by 1,168
Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D., Benz, C. C., & Park, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4199 · Cited by 1,125
Bisht, S., Feldmann, G., Soni, S., Ravi, R., Karikar, C., Maitra, A., & Maitra, A. (2007) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-5-3 · Cited by 1,090
Multistage nanoparticle delivery system for deep penetration into tumor tissue
Wong, C., Stylianopoulos, T., Cui, J., Martin, J., Chauhan, V. P., Jiang, W., Popović, Z., Jain, R. K., Bawendi, M. G., & Fukumura, D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018382108 · Cited by 1,062
Gold nanoparticles as novel agents for cancer therapy
Jain, S., Hirst, D. G., & O'Sullivan, J. M. (2012) · The British Journal of Radiology · doi:10.1259/bjr/59448833 · Cited by 1,059
Minimal "Self" Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles
Rodriguez, P. L., Harada, T., Christian, D. A., Pantano, D. A., Tsai, R. K., & Discher, D. E. (2013) · Science · doi:10.1126/science.1229568 · Cited by 985
Gastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle Size
Desai, M. P., Labhasetwar, V., Amidon, G. L., & Levy, R. J. (1996) · Pharmaceutical Research · doi:10.1023/a:1016085108889 · Cited by 941
Targeting nanoparticles to cancer
Wang, M., & Thanou, M. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.03.005 · Cited by 931
Cancer nanomedicine: A review of recent success in drug delivery
Tran, S., DeGiovanni, P., Piel, B., & Rai, P. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0175-0 · Cited by 879
Lammers, T., Aime, S., Hennink, W. E., Storm, G., & Kiessling, F. (2011) · Accounts of Chemical Research · doi:10.1021/ar200019c · Cited by 870
The Mechanism of Uptake of Biodegradable Microparticles in Caco-2 Cells Is Size Dependent
Desai, M. P., Labhasetwar, V., Walter, E., Levy, R. J., & Amidon, G. L. (1997) · Pharmaceutical Research · doi:10.1023/a:1012126301290 · Cited by 858
Carbon nanotubes as nanomedicines: From toxicology to pharmacology☆
LACERDA, L., BIANCO, A., PRATO, M., & KOSTARELOS, K. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.015 · Cited by 839
Progress in Nanomedicine: Approved and Investigational Nanodrugs.
Ventola, C. L. (2017) · Europe PMC (PubMed Central) · Cited by 835
Bartlett, D. W., Su, H., Hildebrandt, I. J., Weber, W. A., & Davis, M. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707461104 · Cited by 803
Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier.
Kreuter, J., Shamenkov, D., Petrov, V., Ramge, P., Cychutek, K., Koch-Brandt, C., & Alyautdin, R. (2002) · Journal of drug targeting · doi:10.1080/10611860290031877 · Cited by 801
Metal‐based nanoparticles and their toxicity assessment
Schrand, A. M., Rahman, M. F., Hussain, S. M., Schlager, J. J., Smith, D. A., & Syed, A. F. (2010) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.103 · Cited by 753
Recent advances in nanocellulose for biomedical applications
Jorfi, M., & Foster, E. J. (2015) · Journal of Applied Polymer Science · doi:10.1002/app.41719 · Cited by 738
Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy
Li, H.-J., Du, J.-Z., Du, X.-J., Xu, C.-F., Sun, C.-Y., Wang, H.-X., Cao, Z.-T., Yang, X.-Z., Zhu, Y.-H., Nie, S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522080113 · Cited by 724
Multi-walled carbon nanotubes induce T lymphocyte apoptosis
Bottini, M., Bruckner, S., Nika, K., Bottini, N., Bellucci, S., Magrini, A., Bergamaschi, A., & Mustelin, T. (2006) · Toxicology Letters · doi:10.1016/j.toxlet.2005.06.020 · Cited by 679
A Whole Blood Immunoassay Using Gold Nanoshells
Hirsch, L. R., Jackson, J. B., Lee, A., Halas, N. J., & West, J. L. (2003) · Analytical Chemistry · doi:10.1021/ac0262210 · Cited by 676
Light scattering and surface plasmons on small spherical particles
Fan, X., Zheng, W., & Singh, D. J. (2014) · Light: Science & Applications · doi:10.1038/lsa.2014.60 · Cited by 623
Current use of PSMA–PET in prostate cancer management
Maurer, T., Eiber, M., Schwaiger, M., & Gschwend, J. E. (2016) · Nature Reviews Urology · doi:10.1038/nrurol.2016.26 · Cited by 611
Borm, P., Klaessig, F. C., Landry, T. D., Moudgil, B., Pauluhn, J., Thomas, K., Trottier, R., & Wood, S. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj084 · Cited by 586
Arnida, Janát-Amsbury, M. M., Ray, A., Peterson, C. M., & Ghandehari, H. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.11.010 · Cited by 547
Maeda, H., Fang, J., Inutsuka, T., & Kitamoto, Y. (2003) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00271-0 · Cited by 537
Lipid-Based Nanoparticles: Application and Recent Advances in Cancer Treatment
García-Pinel, B., Porras-Alcalá, C., Ortega-Rodríguez, A., Sarabia, F., Prados, J., Melguizo, C., & López-Romero, J. M. (2019) · Nanomaterials · doi:10.3390/nano9040638 · Cited by 527
Examination of Cholesterol oxidase attachment to magnetic nanoparticles
Kouassi, G. K., Irudayaraj, J., & McCarty, G. (2005) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-3-1 · Cited by 506
Biodegradable poly(ε-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen
Chawla, J. S., & Amiji, M. M. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00483-0 · Cited by 487
Nanoparticles evading the reticuloendothelial system: Role of the supported bilayer
Li, S.-D., & Huang, L. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2009.06.022 · Cited by 486
Pardeshi, C. V., & Belgamwar, V. S. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.790887 · Cited by 482 · cited 1×
“Nasal delivery helps drugs to bypass the blood-brain barrier and acts as an efficient platform for brain targeting [107].”
BackgroundPolylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents
Dinarvand, R., Sepehri, N., Manouchehri, Rouhani, & Atyabi, F. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s18905 · Cited by 453
Ecotoxicity of nanoparticles of CuO and ZnO in natural water
Blinova, I., Ivask, A., Heinlaan, M., Mortimer, M., & Kahru, A. (2010) · Environmental Pollution · doi:10.1016/j.envpol.2009.08.017 · Cited by 428
Oh, E., Delehanty, J. B., Sapsford, K. E., Susumu, K., Goswami, R., Blanco-Canosa, J. B., Dawson, P. E., Granek, J., Shoff, M., Zhang, Q., et al. (2011) · ACS Nano · doi:10.1021/nn201624c · Cited by 425
Villella, V. R., Esposito, S., Bruscia, E. M., Maiuri, M. C., Raia, V., Kroemer, G., & Maiuri, L. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00001 · Cited by 389
Tada, H., Higuchi, H., Wanatabe, T. M., & Ohuchi, N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1185 · Cited by 352
Fischer, H. C., Liu, L., Pang, K. S., & Chan, W. C. W. (2006) · Advanced Functional Materials · doi:10.1002/adfm.200500529 · Cited by 347
Barriers to drug delivery in solid tumors
Sriraman, S. K., Aryasomayajula, B., & Torchilin, V. P. (2014) · Tissue Barriers · doi:10.4161/tisb.29528 · Cited by 338
Zhang, C., Jugold, M., Woenne, E. C., Lammers, T., Morgenstern, B., Mueller, M. M., Zentgraf, H., Bock, M., Eisenhut, M., Semmler, W., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1668 · Cited by 336
Semiconductor quantum dot/albumin complex is a long-life and highly photostable endosome marker
Hanaki, K.-I., Momo, A., Oku, T., Komoto, A., Maenosono, S., Yamaguchi, Y., & Yamamoto, K. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00211-0 · Cited by 324
Moen, M. D., Lyseng-Williamson, K. A., & Scott, L. J. (2009) · Drugs · doi:10.2165/00003495-200969030-00010 · Cited by 321
The Toxicity of Silica Nanoparticles to the Immune System
Chen, L., Liu, J., Zhang, Y., Zhang, G., Kang, Y., Chen, A., Feng, X., & Shao, L. (2018) · Nanomedicine · doi:10.2217/nnm-2018-0076 · Cited by 318
Yang, R. S. H., Chang, L. W., Wu, J.-P., Tsai, M.-H., Wang, H.-J., Kuo, Y.-C., Yeh, T.-K., Yang, C. S., & Lin, P. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.10290 · Cited by 314
Pharmacokinetics and distribution of a biodegradable drug-carrier
Grislain, L., Couvreur, P., Lenaerts, V., Roland, M., Deprez-Decampeneere, D., & Speiser, P. (1983) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(83)90166-7 · Cited by 305
The Effect of Nanoparticle Size on the Ability to Cross the Blood–Brain Barrier: An In Vivo Study
Betzer, O., Shilo, M., Opochinsky, R., Barnoy, E., Motiei, M., Okun, E., Yadid, G., & Popovtzer, R. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0022 · Cited by 301
Chen, L., Yokel, R. A., Hennig, B., & Toborek, M. (2008) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-008-9131-5 · Cited by 293
Christian, D. A., Cai, S., Garbuzenko, O. B., Harada, T., Zajac, A. L., Minko, T., & Discher, D. E. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900022m · Cited by 289
Beg, S., Rahman, M., Jain, A., Saini, S., Midoux, P., Pichon, C., Ahmad, F. J., & Akhter, S. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2016.10.001 · Cited by 284
Discovery of transdermal penetration enhancers by high-throughput screening
Karande, P., Jain, A., & Mitragotri, S. (2004) · Nature Biotechnology · doi:10.1038/nbt928 · Cited by 280
Nanotechnology in Medical Imaging: Probe Design and Applications
Cormode, D. P., Skajaa, T., Fayad, Z. A., & Mulder, W. J. M. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.165506 · Cited by 275
Yang, Q., Jones, S. W., Parker, C. L., Zamboni, W. C., Bear, J. E., & Lai, S. K. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400703d · Cited by 269
The use of lipid-based nanocarriers for targeted pain therapies
Hua, S., & Wu, S. Y. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00143 · Cited by 268
Lai, S. K., Hida, K., Man, S. T., Chen, C., Machamer, C., Schroer, T. A., & Hanes, J. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.02.021 · Cited by 264
Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivo
Singh, P., Prasuhn, D., Yeh, R. M., Destito, G., Rae, C. S., Osborn, K., Finn, M. G., & Manchester, M. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.04.003 · Cited by 254
Nanotoxicology of Metal Oxide Nanoparticles
Seabra, A., & Durán, N. (2015) · Metals · doi:10.3390/met5020934 · Cited by 237
Unraveling Stress‐Induced Toxicity Properties of Graphene Oxide and the Underlying Mechanism
Zhang, W., Wang, C., Li, Z., Lu, Z., Li, Y., Yin, J., Zhou, Y., Gao, X., Fang, Y., Nie, G., et al. (2012) · Advanced Materials · doi:10.1002/adma.201202678 · Cited by 230
Pattani, V. P., & Tunnell, J. W. (2012) · Lasers in Surgery and Medicine · doi:10.1002/lsm.22072 · Cited by 223
Characterisation and determination of fullerenes: A critical review
Astefanei, A., Núñez, O., & Galceran, M. T. (2015) · Analytica Chimica Acta · doi:10.1016/j.aca.2015.03.025 · Cited by 221
Antibody-Drug Conjugates for Cancer Therapy: Chemistry to Clinical Implications
Dan, N., Setua, S., Kashyap, V., Khan, S., Jaggi, M., Yallapu, M., & Chauhan, S. (2018) · Pharmaceuticals · doi:10.3390/ph11020032 · Cited by 220
Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers
Kumar, P. V., Asthana, A., Dutta, T., & Jain, N. K. (2006) · Journal of Drug Targeting · doi:10.1080/10611860600825159 · Cited by 215
Fractal Characteristics of Tumor Vascular Architecture During Tumor Growth and Regression
Gazit, Y., Baish, J. W., Safabakhsh, N., Leunig, M., Baxter, L. T., & Jain, R. K. (1997) · Microcirculation · doi:10.3109/10739689709146803 · Cited by 215
Recent progress in nanomaterials for gene delivery applications
Keles, E., Song, Y., Du, D., Dong, W.-J., & Lin, Y. (2016) · Biomaterials Science · doi:10.1039/c6bm00441e · Cited by 213
Bhattacharya, R., Patra, C. R., Earl, A., Wang, S., Katarya, A., Lu, L., Kizhakkedathu, J. N., Yaszemski, M. J., Greipp, P. R., Mukhopadhyay, D., et al. (2007) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2007.07.001 · Cited by 200
Polymeric micelles for oral drug delivery: Why and how
Francis, M. F., Cristea, M., & Winnik, F. M. (2004) · Pure and Applied Chemistry · doi:10.1351/pac200476071321 · Cited by 197
Endothelial Targeting of Cowpea Mosaic Virus (CPMV) via Surface Vimentin
Koudelka, K. J., Destito, G., Plummer, E. M., Trauger, S. A., Siuzdak, G., & Manchester, M. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000417 · Cited by 184
Recent Progress and Advances in Stimuli-Responsive Polymers for Cancer Therapy
Rao, N. V., Ko, H., Lee, J., & Park, J. H. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2018.00110 · Cited by 184
Nanotechnology-based inhalation treatments for lung cancer: state of the art
Akhter, S., Ahmad, J., Rizwanullah, M., Rahman, M., Zaki Ahmad, M., Rizvi, M. M. A., Ahmad, F. J., Amin, S., & Kamal, M. A. (2015) · Nanotechnology, Science and Applications · doi:10.2147/nsa.s49052 · Cited by 174
Self-citationBaqeri, M., Abolhasani, M. M., Mozdianfard, M. R., Guo, Q., Oroumei, A., & Naebe, M. (2015) · Journal of Applied Polymer Science · doi:10.1002/app.42304 · Cited by 172
Needle-free delivery of macromolecules across the skin by nanoliter-volume pulsed microjets
Arora, A., Hakim, I., Baxter, J., Rathnasingham, R., Srinivasan, R., Fletcher, D. A., & Mitragotri, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700182104 · Cited by 168
Zhou, Y., Drummond, D. C., Zou, H., Hayes, M. E., Adams, G. P., Kirpotin, D. B., & Marks, J. D. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.05.011 · Cited by 151
Surface coating mediates the toxicity of polymeric nanoparticles towards human-like macrophages
Grabowski, N., Hillaireau, H., Vergnaud, J., Tsapis, N., Pallardy, M. J., Kerdine‐Römer, S., & Fattal, E. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.11.042 · Cited by 150
Steinmetz, N. F., & Manchester, M. (2009) · Biomacromolecules · doi:10.1021/bm8012742 · Cited by 142
Awada, A. H., Bondarenko, I., Bonneterre, J. M., Nowara, E., Ferrero, J.-M., Bakshi, A. V., Wilke, C., & Piccart, M. J. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu025 · Cited by 142
Yoo, J., Doshi, N., & Mitragotri, S. (2009) · Macromolecular Rapid Communications · doi:10.1002/marc.200900592 · Cited by 130
Engineered nanoparticles induce cell apoptosis: potential for cancer therapy
Ma, D., & Yang, W. (2016) · Oncotarget · doi:10.18632/oncotarget.8553 · Cited by 127
Magnetically triggered release of molecular cargo from iron oxide nanoparticle loaded microcapsules
Carregal‐Romero, S., Guardia, P., Yu, X., Hartmann, R., Pellegrino, T., & Parak, W. J. (2014) · Nanoscale · doi:10.1039/c4nr04055d · Cited by 123
Pandey, P., Rahman, M., Bhatt, P. C., Beg, S., Paul, B., Hafeez, A., Al-Abbasi, F. A., Nadeem, M. S., Baothman, O. A. S., Anwar, F., et al. (2018) · Nanomedicine · doi:10.2217/nnm-2017-0306 · Cited by 120
Quantum dots light up pathology
Tholouli, E., Sweeney, E., Barrow, E., Clay, V., Hoyland, J. A., & Byers, R. J. (2008) · The Journal of Pathology · doi:10.1002/path.2421 · Cited by 115
Santos, J. L., Pandita, D., Rodrigues, J., Pêgo, A. P., Granja, P. L., Balian, G., & Tomás, H. (2010) · Molecular Pharmaceutics · doi:10.1021/mp9002877 · Cited by 110
WGA-grafted PLGA-nanospheres: preparation and association with Caco-2 single cells
Weissenböck, A., Wirth, M., & Gabor, F. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.025 · Cited by 109
Müller, R. H., & Wallis, K. H. (1993) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(93)90304-x · Cited by 106
“Clickable” Polymer-Caged Nanobins as a Modular Drug Delivery Platform
Lee, S., Chen, H., O’Halloran, T. V., & Nguyen, S. T. (2009) · Journal of the American Chemical Society · doi:10.1021/ja9017336 · Cited by 99
Targeting diseased tissues by pHLIP insertion at low cell surface pH
Andreev, O. A., Engelman, D. M., & Reshetnyak, Y. K. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00097 · Cited by 99
Heterogeneity of subcellular localization of p53 protein in human glioblastomas.
Ali, I. U., Schweitzer, J. B., Ikejiri, B. L., Saxena, A., Robertson, J. T., & Oldfield, E. H. (1994) · PubMed · Cited by 88
Ganoderic acid loaded nano-lipidic carriers improvise treatment of hepatocellular carcinoma
Rahman, M., AlGhamdi, S. A., Alharbi, K. S., Beg, S., Sharma, K., Anwar, F., Al-Abbasi, F. A., & Kumar, V. (2019) · Drug Delivery · doi:10.1080/10717544.2019.1606865 · Cited by 88
Xu, Y., Yuen, P.-W., & Lam, J. K. W. (2014) · Pharmaceutics · doi:10.3390/pharmaceutics6030378 · Cited by 85
Cell‐free tumour DNA testing for early detection of cancer – a potential future tool
Barbany, G., Arthur, C., Liedén, A., Nordenskjöld, M., Rosenquist, R., Tesi, B., Wallander, K., & Tham, E. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12897 · Cited by 78
Tumour-selective drug delivery via folate receptor-targeted liposomes
Pan, X., & Lee, R. J. (2004) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.1.1.7 · Cited by 76
Rahman, M., Akhter, S., Ahmad, M. Z., Ahmad, J., Addo, R. T., Ahmad, F. J., & Pichon, C. (2015) · Nanomedicine · doi:10.2217/nnm.15.68 · Cited by 76
Rahman, M., Ahmad, M. Z., Kazmi, I. A., Akhter, S., Afzal, M., Gupta, G., & Sinha, V. R. (2012) · Current Drug Discovery Technologies · doi:10.2174/157016312803305898 · Cited by 69
Emergence of liposome as targeted magic bullet for inflammatory disorders: current state of the art
Rahman, M., Kumar, V., Beg, S., Sharma, G., Katare, O. P., & Anwar, F. (2016) · Artificial Cells Nanomedicine and Biotechnology · doi:10.3109/21691401.2015.1129617 · Cited by 67
Oltra, N. S., Swift, J., Mahmud, A., Rajagopal, K., Loverde, S. M., & Discher, D. E. (2013) · Journal of Materials Chemistry B · doi:10.1039/c3tb20431f · Cited by 66
Ahmad, J., Amin, S., Rahman, M., Rub, R. A., Singhal, M., Ahmad, M. Z., Rahman, Z., Addo, R. T., Ahmad, F. J., Mushtaq, G., et al. (2015) · Current Drug Metabolism · doi:10.2174/1389200216666150812122128 · Cited by 64
Self-citationLingineni, K., Belekar, V., Tangadpalliwar, S. R., & Garg, P. (2017) · Molecular Diversity · doi:10.1007/s11030-016-9715-6 · Cited by 63
Hydrophobic Drug Delivery by Self-Assembling Triblock Copolymer-Derived Nanospheres
Sheihet, L., Dubin, R. A., Devore, D. I., & Kohn, J. (2005) · Biomacromolecules · doi:10.1021/bm050212u · Cited by 60
Al‐Qadi, S., Grenha, A., & Remuñán‐López, C. (2011) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2011.03.022 · Cited by 58
Preda, A., van Vliet, M., Krestin, G. P., Brasch, R. C., & van Dijke, C. F. (2006) · Investigative Radiology · doi:10.1097/01.rli.0000186565.21375.88 · Cited by 58
Cruz, L. J., Tacken, P. J., Eich, C., Rueda, F., Torensma, R., & Figdor, C. G. (2017) · Nanomedicine · doi:10.2217/nnm-2016-0295 · Cited by 58
Enzyme sensitive, surface engineered nanoparticles for enhanced delivery of camptothecin
Yu, H., Chen, J., Liu, S., Lu, Q., He, J., Zhou, Z., & Hu, Y. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.021 · Cited by 57
Development of docetaxel nanocrystals surface modified with transferrin for tumor targeting
Choi, J., & Park, J. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s122984 · Cited by 56
Rahman, M., Ahmad, M. Z., Ahmad, J., Firdous, J., Ahmad, F. J., Mushtaq, G., Kamal, M. A., & Akhter, S. (2014) · Current Drug Metabolism · doi:10.2174/1389200215666141125120633 · Cited by 51
Self-citationA Strategy in The Design of Micellar Shape for Cancer Therapy
Chen, T., Guo, X., Liu, X., Shi, S., Wang, J., Shi, C., Qian, Z., & Zhou, S. (2012) · Advanced Healthcare Materials · doi:10.1002/adhm.201100040 · Cited by 50
Infante, J. R., Keedy, V. L., Jones, S. F., Zamboni, W. C., Chan, E. W., Bendell, J. C., Lee, W., Wu, H., Ikeda, S., Kodaira, H., et al. (2012) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-012-1960-5 · Cited by 49
Rahman, M., Beg, S., Verma, A., Kazmi, I. A., Patel, D. K., Anwar, F., Al-Abbasi, F. A., & Kumar, V. (2017) · Current Drug Targets · doi:10.2174/1389450118666170414113926 · Cited by 48
Yan, J., Xue, F., Chen, H., Wu, X., Zhang, H., Chen, G., Lu, J., Cai, L., Gao, X., Deng, Z., et al. (2014) · Surgical Endoscopy · doi:10.1007/s00464-014-3608-5 · Cited by 40
Nima, Z. A., Alwbari, A. M., Dantuluri, V., Hamzah, R. N., Sra, N., Motwani, P., Arnaoutakis, K., Levy, R. A., Bohliqa, A. F., Nedosekin, D. A., et al. (2017) · Journal of Applied Toxicology · doi:10.1002/jat.3495 · Cited by 40
Role of Lipids in Enhancing Splenic Uptake of Polymer-Lipid (LIPOMER) Nanoparticles
Patil, R. R., Gaikwad, R. V., Samad, A., & Devarajan, P. V. (2008) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2008.320 · Cited by 38
Batist, G., Sawyer, M. B., Gabrail, N., Christiansen, N., Marshall, J. L., Spigel, D. R., & Louie, A. C. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.4108 · Cited by 37
Viruses as nanomedicine for cancer
Yoo, S. Y., Badrinath, N., & Heo, J. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s116447 · Cited by 35
Rahman, M., Beg, S., Aziz, A. N., & Swain, S. (2014) · Current Nanomedicine · doi:10.2174/18779123113036660002 · Cited by 34
Optimizing taxane use in MBC in the emerging era of targeted chemotherapy
von Minckwitz, G., Martín, M., Wilson, G., Alba, E., Schmidt, M., Biganzoli, L., & Awada, A. H. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2012.09.009 · Cited by 32
Novel Approach for the Treatment of Cancer: Theranostic Nanomedicine
Rahman, M., Ahmad, M. Z., Kazmi, I. A., Akhter, S., Kumar, Y., Ahmad, F. J., & Anwar, F. (2012) · Pharmacologia · doi:10.5567/pharmacologia.2012.371.376 · Cited by 26
Cited by
Nanomaterials for cancer therapy: current progress and perspectives
Cheng, Z., Li, M., Dey, R., & Chen, Y. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01096-0 · Cited by 1,168
Emerging Applications of Nanotechnology in Healthcare and Medicine
Malik, S., Muhammad, K., & Waheed, Y. (2023) · Molecules · doi:10.3390/molecules28186624 · Cited by 610
Biodegradable Polymeric Nanoparticles for Drug Delivery to Solid Tumors
Gagliardi, A., Giuliano, E., Venkateswararao, E., Fresta, M., Bulotta, S., Awasthi, V., & Cosco, D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.601626 · Cited by 571
Nakhaei, P., Margiana, R., Bokov, D. O., Abdelbasset, W. K., Jadidi Kouhbanani, M. A., Varma, R. S., Marofi, F., Jarahian, M., & Beheshtkhoo, N. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.705886 · Cited by 479
RetractedNanoparticles in Clinical Translation for Cancer Therapy
Mundekkad, D., & Cho, W. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031685 · Cited by 305
Metadata
- Authors
- Raj, S., Khurana, S., Choudhari, R., Kesari, K. K., Kamal, M. A., Garg, N., Ruokolainen, J., Das, B. C., & Kumar, D.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2021-02
- Volume
- 69
- Pages
- 166-177
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W2983922218
- Cited by
- 425
- References
- 138
- FWCI
- 7.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.